← Eichor
Condition: Stage Iiib Ovarian Cancer Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Stage Iiib Ovarian Cancer

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel i
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05092373
Hyperthermic Intraperitoneal Chemotherapy With Cisplatin During Surgery or Cisplatin Before Surgery for the Treatment of
EARLY_Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT05415709
Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithe
Phase N/A · 1 location(s) · Gynecologic Oncology Group · NCT01000259
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT05039801
Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
Phase N/A · 6 location(s) · Massachusetts General Hospital · NCT04794322
Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy
Phase 2 · 1 location(s) · University of California, Davis · NCT06268665
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
Phase N/A · 2 location(s) · University of Southern California · NCT07259304
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.